Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1993
05/29/1993CA2067519A1 Use of glucocorticoid compounds for the production of compositions for the treatment of disorders in which glucocorticoids are indicated
05/28/1993WO1993010765A1 Controlled release oxycodone compositions
05/28/1993CA2084028A1 Hot flu composition
05/28/1993CA2084018A1 Alkylaminoalkylpyrrolidinylthiocarbapenem derivatives
05/28/1993CA2083798A1 5,6-dihydro-dibenz(b,e) azepine-6,11-dione-11-oximes
05/28/1993CA2083794A1 6-thiono-5,6-dihydro-dibenz(b,e) azepin-11-one-11-oximes
05/28/1993CA2083771A1 Aminoalkyl-substituted 5, 6-dihydro-dibenz (b,e) azepine-6, 11-dione-11-oximes
05/28/1993CA2081679A1 Gem-dialkyl-7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
05/27/1993WO1993010459A1 A method for assaying and treating alzheimer's disease
05/27/1993WO1993010254A1 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase
05/27/1993WO1993010244A1 Synthetic alpha-l-iduronidase and genetic sequences encoding same
05/27/1993WO1993010219A1 Cellular composition for the treatment of human or animal organisms
05/27/1993WO1993010153A1 Bactericidal product, pharmaceutical composition containing same and food additive
05/27/1993WO1993010146A1 Amylin agonist peptides and uses therefor
05/27/1993WO1993010142A1 New lupane derivatives, preparation thereof and pharmaceutical compositions containing them
05/27/1993WO1993010141A2 Angiostatic steroids
05/27/1993WO1993010137A1 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof
05/27/1993WO1993010130A1 Triamino platinum complexes and a method for the synthesis thereof
05/27/1993WO1993010123A1 Process for the preparation of cephem derivatives
05/27/1993WO1993010120A1 Marcfortine/paraherquamide derivatives useful as antiparasitic agents
05/27/1993WO1993010116A1 Triazine derivatives for enhancing antitumor activity
05/27/1993WO1993010115A1 Amorphous (quinolin-2-ylmethoxy) indoles as leukotriene antagonists
05/27/1993WO1993010114A1 3-pyridinol derivatives and their use as medicaments
05/27/1993WO1993010113A1 Novel benzothiophene derivative
05/27/1993WO1993010111A1 CONTINUOUS PROCESS FOR THE MANUFACTURE OF 2,5-DIHYDROFURANS FROM η,δ-EPOXYBUTENES
05/27/1993WO1993010107A1 Phenol derivatives as agonists of a cyclic amp dependent protein kinase
05/27/1993WO1993010101A1 Benzimidazole anthelmintic agents
05/27/1993WO1993010097A1 Nitro compounds having vasodilator activity
05/27/1993WO1993010094A1 Novel substituted salicyclic acids
05/27/1993WO1993010093A1 2-pyridinol derivatives and their use as medicaments
05/27/1993WO1993010092A1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
05/27/1993WO1993010091A2 Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
05/27/1993WO1993010089A1 Novel amide compounds and medicinal use thereof
05/27/1993WO1993010087A1 Derivatives of cyclic phenolic thioethers as inhibitors or stimulators of superoxide generation
05/27/1993WO1993010078A1 New non ionic iodized agents for x-ray contrasting method for preparing them and galenical compositions containing them
05/27/1993WO1993010075A1 N-trityl aspartic acid derivatives for preparing phosphonate nmda antagonists
05/27/1993WO1993010073A1 Acyclic ethylenediamine derivatives as substance p receptor antagonists
05/27/1993WO1993009820A1 System employing a sterile medical solution containing glucose or glucose-like compounds and a solution intended for said system
05/27/1993WO1993009815A1 Specific tolerance in transplantation
05/27/1993WO1993009810A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses
05/27/1993WO1993009805A1 Polar lipid composition of plant origin
05/27/1993WO1993009796A1 Use of interleukin-8
05/27/1993WO1993009795A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprising them
05/27/1993WO1993009790A1 Methods of inhibiting restenosis
05/27/1993WO1993009789A1 Treatment of melanoma with antisense oligonucleotides to c-myb proto-oncogene
05/27/1993WO1993009787A1 Emulsions containing alkyl- or alkylgylcerophosphoryl choline surfactants and methods of use
05/27/1993WO1993009786A1 Phosphorylated flavanoids in the treatment of viral diseases
05/27/1993WO1993009785A1 Risedronate delayed-release compositions
05/27/1993WO1993009784A1 Unit dose form of bismuth subsalicylate
05/27/1993WO1993009782A1 Combination chemotherapy
05/27/1993WO1993009781A1 Sustained-release trapidil tablet
05/27/1993WO1993009780A1 Use of sulphonyl compounds
05/27/1993WO1993009779A1 Methods for increasing the sensitivity and decreasing the side effects of pharmacological stress testing for coronary artery disease
05/27/1993WO1993009778A2 Use of brl 38227 for the treatment and prophylaxis of hyperlipidemia
05/27/1993WO1993009777A1 Tocotrienols and tocotrienol-like compounds and methods for their use
05/27/1993WO1993009776A1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones
05/27/1993WO1993009775A1 Unbuffered premixed ranitidine formulation
05/27/1993WO1993009774A1 2-(4-substituted)phenylmethylene derivatives and methods of use
05/27/1993WO1993009773A1 Preventive or curative for dysmenorrhea and food having function of preventing dysmenorrhea
05/27/1993WO1993009772A1 Drug for hepatic diseases
05/27/1993WO1993009771A1 Controlled release flutamide composition
05/27/1993WO1993009770A1 Bactericidal pharmaceutical composition containing chlorhexidine and eugenol
05/27/1993WO1993009769A1 Methods and compositions utilizing pure s(+) isomer fluoxetine
05/27/1993WO1993009768A1 Fomentation containing ketorolac
05/27/1993WO1993009767A1 Prolonged release diltiazem-based formulation
05/27/1993WO1993009764A1 Combined virustatic antimediator (covam) treatment of common colds
05/27/1993WO1993009762A2 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
05/27/1993WO1993007866A3 Compositions and methods for therapy and prevention of cancer, aids, and anemia
05/27/1993WO1993006812A3 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases
05/27/1993WO1993001820A3 Inhibition of non-cd4 mediated hiv infection
05/27/1993WO1992000067A3 Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists
05/27/1993DE4139224A1 Self-treatment of non-infectious, and non-hereditary illnesses e.g. Alzheimer's disease etc. - by increasing hydrogen content directly and slightly increasing indole and cortisone content by using high protein alkali diet e.g. including egg white, lean poultry etc.
05/27/1993CA2425846A1 Angiostatic steroids
05/27/1993CA2124857A1 Methods of inhibiting restenosis
05/27/1993CA2124086A1 Tocotrienols and tocotrienol-like compounds and methods for their use
05/27/1993CA2124003A1 Phenol derivatives as agonists of a cyclic amp dependent protein kinase
05/27/1993CA2124002A1 3-pyridinol derivatives and their use as medicaments
05/27/1993CA2124001A1 2-pyridinol derivatives and their use as medicaments
05/27/1993CA2123782A1 Process for the preparation of pharmaceutically active thiazolidine or oxazolidine compounds by a yeast reductase
05/27/1993CA2123611A1 Treatment of melanoma with antisense oligonucleotides to c-myb proto-oncogene
05/27/1993CA2123587A1 Bactericide product; pharmaceutical composition and food additive containing the same
05/27/1993CA2123585A1 Polar lipidic composition from plants
05/27/1993CA2123569A1 Nitro compounds having vasodilator activity
05/27/1993CA2123486A1 Method for extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
05/27/1993CA2123402A1 Triazine derivatives for enhancing antitumor activity
05/27/1993CA2123228A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses
05/27/1993CA2123109A1 Ketorolac-containing fomentation
05/27/1993CA2122719A1 Combined virustatic antimediator (covam) treatment of common colds
05/27/1993CA2122641A1 Phosphorylated flavanoids in the treatment of viral diseases
05/27/1993CA2121835A1 N-trityl aspartic acid derivatives for preparing phosphonate nmda antagonists
05/27/1993CA2121692A1 New lupane derivatives, preparation thereof and pharmaceutical compositions containing them
05/27/1993CA2121502A1 Emulsions containing alkyl-or alkylglycerophosphoryl choline surfactants and methods of use
05/27/1993CA2121234A1 Marcfortine/paraherquamide derivatives useful as antiparasitic agents
05/27/1993CA2120134A1 Derivatives of cyclic phenolic thioethers as inhibitors or stimulators of superoxide generation
05/27/1993CA2117285A1 Use of interleukin-8
05/27/1993CA2117282A1 Non-peptidic surrogates of the arg-gly-asp sequence and pharmaceutical compositions comprosing them
05/27/1993CA2100466A1 Unbuffered premixed ranitidine formulation
05/27/1993CA2083622A1 Certain macrocyclic lactam derivatives
05/27/1993CA2083570A1 Combination having a neuroprotective effect
05/27/1993CA2083440A1 Urea fusion process for the synthesis of 3-phenoxy-1-azetidinecarboxamides
1 ... 7190 7191 7192 7193 7194 7195 7196 7197 7198 7199 7200 7201 7202 7203 7204 7205 7206 7207 7208 7209 7210 ... 7860